Structure of the MRAS-SHOC2-PP1C phosphatase complex

Area of Science:

• Molecular Biology
• Structural Biology
• Cell Signaling

Background:

• RAS-MAPK signaling is vital for cell proliferation and frequently altered in human cancers.
• The precise mechanism of RAS signaling through RAF, particularly intermediate activation steps, remains incompletely understood.
• The MRAS-SHOC2-PP1C holophosphatase complex plays a key role in RAF dephosphorylation and activation, with mutations linked to rasopathies and cancer.

Purpose of the Study:

• To elucidate the structural basis of the MRAS-SHOC2-PP1C holophosphatase complex.
• To understand the molecular mechanisms underlying RAS-driven RAF activation.
• To investigate how mutations in this complex contribute to disease pathogenesis.

Main Methods:

• X-ray crystallography was employed to determine the high-resolution structure of the MRAS-SHOC2-PP1C complex.
• Biophysical characterization techniques were used to assess complex assembly and dynamics.
• Analysis of mutation sites within the context of the determined structure.

Main Results:

• The crystal structure reveals SHOC2 acting as a scaffold, bridging MRAS and PP1C, facilitating interactions between all three components.
• Complex assembly is cooperatively driven by the active, GTP-bound state of MRAS, a mechanism applicable to other RAS isoforms.
• Mutations associated with rasopathies and cancer were found at protein-protein interfaces, enhancing complex stability and function.

Conclusions:

• The study presents a multi-molecular model for RAF activation, driven by RAS-GTP, involving the recruitment of RAF-14-3-3 and the SHOC2-PP1C holophosphatase.
• The findings provide critical structural insights into RAS-MAPK pathway regulation and the molecular basis of diseases caused by its aberrant activation.
• This structural understanding offers a foundation for developing targeted therapeutic interventions for RAS-driven cancers and rasopathies.